We found that the inhibition of PI3K, even if irreversible, has no impact on GBM metabolic activity; moreover, by reducing only transiently AKT phosphorylation, wortmannin does not affect the ability of GBM cells to cycle and proliferate, even in presence of wild type PTEN genotype. This evidence concerns the gene PTEN and glioblastoma.